期刊文献+

100例高血压患者中医体质辨识分析 被引量:4

An Investigation and Analysis of the Traditional Chinese Medicine Constitution of 100 Patients with Hypertension
下载PDF
导出
摘要 目的:了解老隆镇高血压患者的中医体质分布情况,为当地高血压患者的保健及治疗提供中医体质学的建议,提高患者生活质量。方法:通过问卷对老隆镇高血压患者进行体质调查及辨析,根据问卷结果对其中医体质分布进行统计分析。结果:共发放中医体质辨识调查问卷110份,回收100份有效问卷,调查有效率为90.9%。调查显示,当地高血压患者体质以阴虚质最多见(33%),其次为痰湿质(21%),占比例较多的还有湿热质(14%)、阳虚质(10%)和血瘀质(8%)。结论:当地高血压患者的中医体质分布较广,临床医生应根据不同患者的疾病情况并结合其中医体质制定相应的治疗和保健方案,以提高疗效和患者的生活质量。 Objective Investigate the distribution of TCM constitution of patients with hypertension in Laolong town to identify and analyze the TCM constitution of local hypertensive patients, and to provide Chinese medicine physique advice for future treatment of patients. Methods Through the questionnaire, the physical examination and analysis of the hypertension patients in Laolong Town were carried out, and the distribution of the medical constitution was analyzed according to the results of the questionnaire. Results A total of 110 questionnaires on TCM constitution identification were distributed, and 100 valid questionnaires were collected. The effective rate of the survey was 90.9 %. According to the survey, the local physique of Yindeficient constitution is the most common(33 %), followed by phlegm-dampness constitution(21 %), and the proportion of dampheat constitution(14 %) and Yang-deficient constitution(10 %). And stagnant blood constitution(8 %). Conclusion The TCM constitution of patients with hypertension are various. Physicians should develop treatment plans based on the different TCM constitution of patients to improve the efficacy.
作者 王冬盈 梁玥玥 WANG Dong-ying;LIANG Yue-yue(The First Clinical Medical College of Guangzhou University of Chinese Medicine,Guangdong Guangzhou 510006)
出处 《深圳中西医结合杂志》 2018年第19期55-58,共4页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
关键词 中医体质 高血压 辨证分型 TCM Constitution Hypertension Differentiation of symptoms
  • 相关文献

参考文献4

二级参考文献40

  • 1中华中医药学会.中医体质分类与判定[M].北京:中国中医药出版社,2009:26.
  • 2孔灵芝,胡盛寿.中国心血管病报告2006[M].北京:中国大百科全书出版社,2008.
  • 3Redwood H. Hypertension, society, and public policy [J]. Eur Heart J, 2007, 9(Suppl B): B13-B18.
  • 4Sarafidis PA, Bakris GL. Resistant hypertension., an overview of evaluation and treatment[J]. J Am Coil Cardiol, 2008, 52(22): 1749-1757.
  • 5Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study[J]. Prey Med, 2000, 30(4) : 328 - 338.
  • 6Keene LC, Davies PH. Drug-related erectile dysfunction [J]. Adverse Drug React Toxicol Rev, 1999, 18(1).. 5- 24.
  • 7Buranakitjaroen P, Phoojaroenchanachai M, Saravich S. Prevalence of erectile dysfunction among treated hyper tensive males[J]. J Med Assoc Thai, 2006, 89(Suppl 5):28-36.
  • 8Baumhakel M, Sehlimmer N, Bohm M, et al. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome[J]. Int J Impot Res, 2008, 20(5) ~493 - 500.
  • 9Gold PW. Goodwin FK. Chrousos GP. Clinical and biochemical manifestations of depression Relation to the neurobiology of stress(2)[J]. N Engl J Med, 1988, 319 (7):413 -420.
  • 10Waldstein SR, Jennings JR, Ryan CM, et al. Hypertension and neuropsychological performance in men: in- teractive effects of age[J]. Health Psychol, 1996, 15 (2) :102- 109.

共引文献4688

同被引文献70

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部